ARCHIVES

FDA Approves Rituxan For NHL With CHOP Therapy

This article is from The Cancer Letter archive.

Vol. 29 No. 2 | February 24, 2006

Download PDF Visit The Full Archive

Related Articles

Stand Up To Cancer Awards 13 Grants

January 15, 2010

Six Compounds Carcinogenic, Risk to Humans, CH Subgroup Finds

February 2, 1979

Only 10% Of Breast Cancer Patients May Benefit From Contralateral Mastectomy

March 26, 2010

Canadian Products Anticancer Drugs In Plant Culture

April 22, 1983

In Brief: Potter New AACI President, Sartorlli President Elect; NCI Staffers Get NIH Director’s Award

July 18, 1986

FDA Urges Lower Target for ESA Use; Market Could Drop By More Than Half.

March 16, 2007